Literature DB >> 11975979

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.

René J Duquesnoy1, Marilyn Marrari.   

Abstract

HLAMatchmaker is a computer algorithm that assesses human leukocyte antigen (HLA) compatibility at the structural level by intralocus and interlocus comparisons of polymorphic amino acid triplets in antibody-accessible sequences of HLA class I molecules. This program permits the identification of mismatched HLA antigens that share all of their polymorphic triplets with the patient's HLA antigens and, therefore, could be considered fully compatible. The validity of this algorithm has been verified by analyzing the antibody specificity patterns of 127 well-characterized sera (panel reactive antibody [PRA] > 80%) that had been screened by direct complement-dependent and/or anti-human globulin augmented lymphocytotoxicity testing with large HLA-typed cell panels. A 2 x 2 table-based Chi-square analysis program was applied to determine positive and negative correlations between serum reactivity and the presence HLA triplets assigned from the HLA types in the cell panel. The results indicate that high PRA patients do not produce antibodies to shared triplets on mismatched HLA antigens. Moreover, this serum analysis has permitted the identification of triplets with different degrees of immunogenicity as indicated by the frequencies of positive and negative correlations of serum reactivity with the HLA-typed cell panel. Mismatching for triplets with low immunogenicity provides further opportunities for identifying donors with acceptable HLA mismatches for highly sensitized patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11975979     DOI: 10.1016/s0198-8859(02)00381-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  A structurally based approach to determine HLA compatibility at the humoral immune level.

Authors:  Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2006-09-01       Impact factor: 2.850

Review 2.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Authors:  Rene J Duquesnoy; Medhat Askar
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

4.  HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

Authors:  Ashok Nambiar; Rene J Duquesnoy; Sharon Adams; Yingdong Zhao; Jaime Oblitas; Susan Leitman; David Stroncek; Francesco Marincola
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

5.  Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

Authors:  Marilyn Marrari; Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2009-03-09       Impact factor: 2.850

6.  HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.

Authors:  Rene Duquesnoy; Stephen Spellman; Michael Haagenson; Tao Wang; Mary M Horowitz; Machteld Oudshoorn
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

Review 7.  Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome.

Authors:  Kirsten A Thus; Liane Te Boome; Jürgen Kuball; Eric Spierings
Journal:  Front Immunol       Date:  2014-05-12       Impact factor: 7.561

Review 8.  The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.

Authors:  Edward J Filippone; John L Farber
Journal:  J Immunol Res       Date:  2016-12-14       Impact factor: 4.818

9.  Correlation and agreement between eplet mismatches calculated using serological, low-intermediate and high resolution molecular human leukocyte antigen typing methods.

Authors:  Samantha Fidler; Lloyd D'Orsogna; Ashley B Irish; Joshua R Lewis; Germaine Wong; Wai H Lim
Journal:  Oncotarget       Date:  2018-02-01

10.  Pyrosequencing trade mark : A one-step method for high resolution HLA typing.

Authors:  Daniel Ramon; Megan Braden; Sharon Adams; Francesco M Marincola; Lu Wang
Journal:  J Transl Med       Date:  2003-11-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.